Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES2 | Q9H7Z7 | 2/20 | 0.41 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.36 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.36 |
| ▸ | PTPN5 | P54829 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6411955 | 0.79 | CKS1B (0.41) | ALDH1A1CA1CA2CA9SIRT2 | |
| SCHEMBL6410524 | 0.78 | ITK (0.52) | ALDH1A1HSD17B10 | |
| SCHEMBL6414608 | 0.76 | ITK (0.38) | ALDH1A1CA1CA2CA9MAP2K4 | |
| SCHEMBL6410600 | 0.70 | AURKA (0.47) | ALDH1A1KDRCA1CA2CA9 | |
| SCHEMBL6410604 | 0.70 | AURKA (0.47) | ALDH1A1KDRCA1CA2CA9 | |
| SCHEMBL6410631 | 0.70 | ITK (0.55) | BCAT1MEN1MAPTKMT2AKDM4E | |
| SCHEMBL18493829 | 0.66 | BCAT1 (0.54) | PTGES2BCAT1PTPN1PTPN2PTPN5 | |
| SCHEMBL6414478 | 0.65 | BCAT1 (0.38) | PTGES2BCAT1PTPN1PTPN2PTPN5 | |
| SCHEMBL4009029 | 0.65 | ITK (0.48) | MEN1KMT2A | |
| SCHEMBL1098417 | 0.63 | LMNA (0.50) | MEN1KMT2AALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050026984-A1 | Substituted thieno [2,3-c] pyrazoles and their use as medicinal products | AVENTIS PHARMA S.A. (FR) | 2005-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050026984-A1 | Substituted thieno [2,3-c] pyrazoles and their use as medicinal products | TPMT, PARK7, PRNP | PTGES2 618/4885BCAT1 2316/4885PTPN1 3578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.